Journal article
Defining and managing suicidal risk in patients taking psychotropic medications
The journal of clinical psychiatry, Vol.70(6), pp.782-789
06/2009
DOI: 10.4088/JCP.8145co0c
PMID: 19573477
Abstract
In March 2004, the US Food and Drug Administration (FDA) issued a public health advisory warning that antidepressant treatment may
increase suicidality and worsen depression in adult and pediatric patients. Then, in May 2007, the FDA proposed that the black box warning in the prescribing information for antidepressants and other drugs used to treat depression be updated to include a warning about an increased risk of suicidality in young adults. In January 2008, the FDA announced that antiepileptic medication labeling will be required to include a warning about an increased risk of suicidality
Details
- Title: Subtitle
- Defining and managing suicidal risk in patients taking psychotropic medications
- Creators
- Jan A Fawcett - Department of Psychiatry, University of New Mexico School of Medicine, Albuquerque, NM, USARoss J BaldessariniWilliam H CoryellMorton M SilvermanDan J Stein
- Resource Type
- Journal article
- Publication Details
- The journal of clinical psychiatry, Vol.70(6), pp.782-789
- DOI
- 10.4088/JCP.8145co0c
- PMID
- 19573477
- NLM abbreviation
- J Clin Psychiatry
- ISSN
- 0160-6689
- eISSN
- 1555-2101
- Publisher
- United States
- Language
- English
- Date published
- 06/2009
- Academic Unit
- Psychiatry
- Record Identifier
- 9984003437902771
Metrics
22 Record Views